NCT05286684 2026-03-18
Exo-LCR
Centre Oscar Lambret
Phase NA Completed
Clinical Trials
8 trialsNCT06592092 2026-01-29
Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Completed
NCT07348965 2026-01-16
Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
Guangzhou University of Traditional Chinese Medicine
Phase NA Not yet recruiting
NCT05746325 2025-10-27
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
Mayo Clinic
Phase NA Recruiting
NCT06304441 2025-09-29
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Guangzhou Medical University
Phase NA Recruiting
NCT03974204 2025-09-26
Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.
Centre Oscar Lambret
Phase NA Withdrawn
NCT06984523 2025-05-25
Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis
NYU Langone Health
Phase NA Not yet recruiting
NCT05746754 2025-04-06
CSI ProLong
University of Aarhus
Phase NA Recruiting